Nociceptive neurons of the dorsal root ganglion (DRG) express a combination of rapidly gating TTX-sensitive and slowly gating TTX-resistant Na currents and the channels that produce these currents have been cloned. The Na v 1.7 and Na v 1.8 channels encode for the rapidly inactivating TTX-sensitive and slowly inactivating TTX-resistant Na currents respectively. Although the Na v 1.7 channel expresses well in cultured mammalian cell lines, attempts to express the Na v 1.8 channel using similar approaches has been met with limited success. The inability to heterologously express Na v 1.8 has hampered detailed characterization of the biophysical properties and pharmacology of these channels. In this study we investigated the determinants of Na v 1.8 expression in tsA201 cells, a transformed variant of HEK293 cells, using a combination of biochemistry, immunochemistry and electrophysiology. Our data indicate that the unusually low expression levels of Na v 1.8 in tsA201 cells results from a trafficking defect that traps the channel protein in the endoplasmic reticulum. Incubating the cultured cells with the local anesthetic lidocaine dramatically enhanced the cell surface expression of functional Na v 1.8 channels. The biophysical properties of the heterologously expressed Na v 1.8 channel are similar but not identical to those of the TTX-resistant Na current of native DRG neurons, recorded under similar conditions. Our data indicates that the lidocaine acts as a molecular chaperone that promotes efficient trafficking and increased cell surface expression of Na v 1.8 channels.
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Abstract:
Nociceptive neurons of the dorsal root ganglion (DRG) express a combination of rapidly gating TTX-sensitive and slowly gating TTX-resistant Na currents and the channels that produce these currents have been cloned. The Na v 1.7 and Na v 1.8 channels encode for the rapidly inactivating TTX-sensitive and slowly inactivating TTX-resistant Na currents respectively. Although the Na v 1.7 channel expresses well in cultured mammalian cell lines, attempts to express the Na v 1.8 channel using similar approaches has been met with limited success. The inability to heterologously express Na v 1.8 has hampered detailed characterization of the biophysical properties and pharmacology of these channels. In this study we investigated the determinants of Na v 1.8 expression in tsA201 cells, a transformed variant of HEK293 cells, using a combination of biochemistry, immunochemistry and electrophysiology. Our data indicate that the unusually low expression levels of Na v 1.8 in tsA201 cells results from a trafficking defect that traps the channel protein in the endoplasmic reticulum. Incubating the cultured cells with the local anesthetic lidocaine dramatically enhanced the cell surface expression of functional Na v 1.8 channels. The biophysical properties of the heterologously expressed Na v 1.8 channel are similar but not identical to those of the TTX-resistant Na current of native DRG neurons, recorded under similar conditions. Our data indicates that the lidocaine acts as a molecular chaperone that promotes efficient trafficking and increased cell surface expression of Na v 1.8 channels.
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Page 2 of 42 4 channels (Akopian et al. 1996; Sangameswaran et al. 1996) . The Na v 1.8 channel has been expressed in Xenopus oocytes and the properties of the heterologously expressed channels are in good agreement with those of the native TTX-R Na current of DRG neurons (Akopian et al. 1996; Sangameswaran et al. 1996; Vijayaragavan et al. 2001) . By contrast, attempts to heterologously express the Na v 1.8 channel in cultured mammalian cells have been met with limited success (John et al. 2004; Vijayaragavan et al. 2004) .
Although the reasons for the poor expression of the Na v 1.8 channels in cultured cells are not known, it is generally believed to result from a trafficking defect that reduces the cell surface expression of functional channels (Okuse et al. 2002) .
A number of factors appear to regulate the expression of Na v 1.8 channel in mammalian cell lines. Interaction of Na v 1.8 with accessory proteins appears to either promote the translocation to the plasma membrane or stabilize channels within the plasma membrane. Annexin II light chain (p11) enhances Na v 1.8 expression by directly interacting with the cytoplasmic N-terminus of the channel protein resulting in translocation to the plasma membrane (Okuse et al. 2002) . Co-expression of the accessory 3 subunit, annexin II light chain (p11), and clatherin-associated protein-1A (CAP-1A) appear to be important regulators of Na v 1.8 expression (John et al. 2004; Okuse et al. 2002; Liu et al. 2005) . While 3 and p11 were reported to enhance cell surface expression, CAP-1A reduces the density of the expressed Na v 1.8.
Despite the enhanced trafficking produced by accessory proteins ( 3 and p11), the current density of the heterologously expressed Na v 1.8 channel remains relatively low by comparison to the native TTX-R current of DRG neurons and the Na v 1.7 channel expressed under similar conditions . As yet unidentified factors or regulatory mechanisms appear to contribute to the efficient trafficking and cell surface expression of the Na v 1.8 channel. Increases in nociceptor excitability and changes in the level and distribution of Na v 1.8 expression were associated with acute nerve injury and inflammatory reactions (McCleskey and Gold 1999) . Understanding the mechanisms governing Na v 1.8 trafficking therefore has important implications for the peripheral sensitization to painful stimuli linked to tissue damage and nerve injury.
Recently, it has been shown that in several channelopathies, mutation in channel proteins that induce misfolding and therefore the retention of the channel in the ER can be rescued (Morello et al. 2000) . This is the case for mutations that cause the Brugada syndrome an inherent cardiac disorder, and that the defect of the misfolding was rescued by the antiarrhythmic drug mexiletine (Valdivia et al. 2002) .
Chemical chaperones are small molecules that assist folding and restore the trafficking of receptors and channels (Morello et al. 2000) . In this study we investigated the effects of the local anesthetic lidocaine on the expression of the Na v 1.8 channel in tsA201 cells, a transformed variant of the HEK293 cell line. Our data indicate that lidocaine acts as a chemical chaperon that promotes Na v 1.8 trafficking to the plasma membrane. The biophysical properties of the heterologously expressed Na v 1.8 channels are similar to but not identical to those of the TTX-resistant Na current recorded under identical conditions from DRG neurons.
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Material and methods
Heterologous expression of Nav1.8 in tsA201 cells
The tsA201 cell line is a mammalian cell line derived from human embryonic kidney HEK 293 cells by stable transfection with SV40 large T antigen (Margolskee et al. 1993 ).
Cells were grown in high glucose DMEM supplemented with FBS (10%), L-glutamine (2 mM), penicillin (100 U/ml) and streptomycin (10 mg/ml) (Gibco BRL Life technologies, Burlington, Ontario). Cells were incubated in a 5% CO 2 humidified atmosphere.
Transfections of tsA201 cells were carried out using the calcium phosphate method as previously described (Margolskee et al. 1993 ).
The 1 -subunit was co-expressed with Na v 1.8. The human Na + channel 1 -subunit and CD8 were constructed in the piRES vector (piERS/CD8/ ) (Invitrogene Corporation, Carlsbad, CA). Transfected cells were briefly (<5 minutes) pre-incubated with CD8
antibody coated beads prior to recording (Dynabeads M-450 CD8-a). Cells expressing the piRES/CD8/ 1 bicistronic vector were decorated with CD8 beads, which were used to identify cells for patch-clamp analysis (Margolskee et al. 1993 ). Transfected tsA201 cells were then pre-treated for 24 hours with 1 mM lidocaine. The cells were subsequently incubated for 3-4 hours in lidocaine-free media immediately prior to electrophysiological recordings.
Isolation of dorsal root ganglion neurons
Seven day-old rat pups are anesthetized with isoflurane before decapitation and the dorsal root ganglia from all accessible levels of the spinal cord harvested. Excess connective tissues were removed and the ganglion placed in 3 ml of Hank's Balanced Salt Solution (HBSS, Gibco) supplemented with 10 mM HEPES. The ganglions were incubated for 30 minutes at 37 o C in 2 ml of HBSS/HEPES containing 1.5 mg/ml collagenase (Sigma-Aldrich, St. Louis, MO). The ganglia were washed with HBSS/HEPES before adding 1 mg/ml trypsin (Sigma-Aldrich) and incubating an additional 30 minutes at 37 o C. Trypsin was removed and the ganglia were transferred to L-15 Leibovitz media (Gibco) supplemented with 1% fetal bovine serum (FBS, Gibco), 2 mM glutamine, 24 mM NaHCO 3 , 38 mM glucose, 2% penicillin-streptomycin (Gibco), and 50 ng/ml nerve growth factor (Sigma-Aldrich). The ganglia were dissociated by 7 gentle titration using fire-polished Pasteur pipettes and the dissociated neurons plated onto 35 mm dishes containing 2 ml of the supplemented Leibovitz media. Dissociated neurons (<20 µm, 8-12 pF of capacitance) were suitable for patch clamp studies 1-2 hour after plating. Neonatal rats were euthanized in accordance with the Animal Welfare protocols of our institution.
Electrophysiology
Macroscopic Na currents from tsA201 transfected cells were recorded using the whole-cell configuration of the patch clamp technique ). Command pulses were generated and current recorded using pCLAMP software v8.0 and an Axopatch 200 amplifier (Molecular Devices, Union City, CA). Patch electrodes were fashioned from borosilicate glass (Corning 8161) and coated with Sylgard (Dow-Corning, Midland, MI) to minimize stray capacitance. Current recordings were made using low resistance electrodes (<1M ) and the series resistance compensated at values >80%, to minimize voltage-clamp errors. Whole-cell currents were filtered at 5 kHz, digitized at 10 kHz, and stored on a microcomputer equipped with an AD converter (Digidata 1300, Molecular Devices). Data analysis was performed using a combination of pCLAMP software v9.0 (Molecular Devices), Microsoft Excel and SigmaPlot for Windows version 8.0 (SPSS Inc., Chicago, IL). The current signal was low pass filtered at 2 kHz and digitalized at a sampling rate of 100µs during acquisition. Traces shown were low pass filtered at 1.5 KHz using a digital filter of Clampfit software.
Solutions and reagents
For whole cell recordings, the patch pipette contained 5 mM NaCl, 135 mM CsF, 10 mM EGTA and 10 mM Cs-HEPES. The pH was adjusted to 7.4 using 1 N CsOH. The bath solution contained 150 mM NaCl, 2 mM KCl, 1.5 mM CaCl 2 , 1 mM MgCl 2 10 mM glucose and 10 mM Na-HEPES. The pH was adjusted to 7.4 with 1 N NaOH. For Na current recording from DRG neurons the extracellular solution contained instead 140 mM NaCl and the intracellular solution contained 35 mM NaCl. A correction for the liquid junction potential between the patch pipette and the bath solutions (-7 mV) was applied to the command pulses. The recordings were made 10 min after obtaining the whole cell configuration in order to allow the current to stabilize and to fully dialyze the cell with pipette solution. The Na v 1.8 -subunit and the 1 auxiliary subunit were cloned in our laboratory as described previously (Vijayaragavan et al. 2001 ).
For single channel recording, 3-5 M patch electrodes were used. Patch electrodes were coated with Sylgard to reduce their capacitance and lower noise emission. The bath solution contained a high concentration of potassium composed of 100 mM K-aspartate, 50 mM KCl, 1.5 CaCl 2 , 1 mM MgCl 2 , 10 mM glucose and 10 mM K-HEPES (pH = 7.4).
This solution was used to depolarize the cell thereby making the applied command potential approximately equal to the voltage across the membrane patch. The patch pipette solution contained 150 mM NaCl, 10 mM TEA-Cl, (to block endogenous potassium channels), 2 mM KCl, 1.5 mM CaCl 2 , 1 mM MgCl 2 , 10 mM glucose, 10 Na-HEPES (pH = 7.4). Single-channel currents were recorded using an Axopatch 200B
amplifier, a Digidata 1200 acquisition system, and pCLAMP v9 (Molecular Devices).
Single channel currents were filtered at 2 kHz and sampled at 100 kHz. Single channel currents were recorded at room temperature (22-23 o C).
Immunocytochemistry
Transfected tsA201 cells were permeabilized using 0.1% Triton in 1 mM PBS-0.5%
BSA solution before incubation with antibodies. Cells were fixed using a 1:3 acetone/methanol solution for 20 minutes. The mouse anti-Na v 1.8 primary antibody
(1:100) was used against the Na v 1.8 alpha-subunit (Alomone, Jerusalem). The secondary antibody was a conjugated AffiniPure goat anti-mouse (1:400) (Molecular Probes Inc., Eugene, OR). Rabbit Anti-Calnexin polyclonal antibody (1:4000) was used for endoplasmic reticulum (ER) labeling, and was obtained from StressGen Biotechnologies
Corp (Victoria, British Columbia).
Confocal Microscopy
Fluorescent probe-labelled tsA201 cells were examined on a Bio-Rad MRC-1024
confocal imaging system equipped with a krypton-argon laser beam mounted on a Zeiss 
Western blot analysis
tsA201 cells were washed with phosphate-buffered saline (PBS, pH 7.4) and solubilized in 1 ml of STEN buffer consisting of: 0.2% NP40, 1% Triton X-100 and protease inhibitor mixture (Roche Molecular Biochemicals, Mannhein, Germany).
Insoluble debris were removed by centrifugation at 13,000 rpm for 30 minutes.
Equivalent amounts of proteins were applied to an SDS-10% PAGE electrophoresis gel and the separated proteins transferred to a Hybond P membrane (Amersham Pharmacia Biotech, Piscataway, NJ). After protein transfer, the membrane was blocked for 1 h at room temperature in 5% non-fat milk in PBS-T (0.1 % tween -20 in PBS, pH 7.4). The membranes were probed with anti-Na v 1.8 antibody (1/200 dilution) (Alomone), followed by horseradish peroxidase-conjugated goat anti-rabbit (1/10000 dilution) (Amersham Pharmacia Biotech) and ECL detection (Amersham Pharmacia Biotech).
Results
Lidocaine enhances the cell surface expression of the Na v 1.8 channel
Since the cloning of Na v 1.8 in 1996 (Sangameswaran et al. 1996) , the heterologous expression of this Na channel in mammalian cells has proved to be problematic, often ). This has complicated efforts to study the biophysical properties of the heterologously expressed channel. The poor expression of Na v 1.8 in cultured cell lines is generally believed to result from a trafficking defect that prevents the channel protein from reaching the plasma membrane (Okuse et al. 2002) . To further investigate the underlying mechanism we used immunohistochemistry and confocal imaging to study the sub-cellular localization of the Na v 1.8 channel heterologously expressed in tsA201 cells.
Immunofluorescence revealed a significant accumulation of Na v 1.8 in perinuclear regions ( Figure 1A , green staining) that displayed significant overlap with the immunostaining for calnexin, a specific marker of the endoplasmic reticulum (ER) ( Figure 1B , red staining). The overlap of the Na v 1.8 and calnexin ( Figure 1C , yellow staining) suggests that the majority of the channel protein is localized within intracellular organelles with little distribution to the plasma membrane.
We found that pre-incubating Na v 1.8 transfected tsA201 cells with lidocaine (1 mM)
for 24 hours prior to immunohistochemical examination dramatically altered the subcellular distribution of the Na v 1.8 channel. Lidocaine substantially reduced the Na v 1.8
immunofluorescence of the perinuclear region ( Figure 1D ) and reduced the overlap with calnexin ( Figure 1E ). Preincubating the cells with lidocaine shifted Na v 1.8 staining away from the intracellular compartment and toward the cell periphery ( Figure 1F ).
The immunohistochemistry suggests that lidocaine may act by enhancing the trafficking of the Na v 1.8 channels from the ER to the plasma membrane. Alternatively, the observed changes in Na v 1.8 distribution could have resulted from the synthesis of new channel protein that was specifically targeted to the cell periphery. To distinguish between these alternatives we used western blot analysis to investigate the effects of lidocaine on the expression of Na v 1.8 channel protein. Figure 2A shows the western blot of the Na v 1.8 channel expressed in tsA201 cells pre-incubated under control conditions or after 24 hours incubation with lidocaine (1 mM). The expression levels of the Na v 1.8 channels were similar under both conditions suggesting that the increase in peripheral Na v 1.8 immunostaining induced by lidocaine ( Figure 1F ) does not result from the synthesis of new channel protein.
The underlying mechanism was further investigated by specifically labelling the Na v 1.8 channels expressed on the cell surface of transfected tsA201 cells with biotin.
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The labeled cells were then lysed and the biotinylated proteins purified by NeutrAvidin gel filtration. Figure 2B shows the Western analysis of the biotinylated Na v 1.8 channels Figure 3B ) by comparison to drug-free controls ( Figure 3A ).
To quantitate these findings, the peak Na current amplitudes were normalized to the whole-cell capacitance of individual cells ( Figure 3C or 3D). Preincubating with lidocaine induced a significant 6-fold increase in the Na current density (-123.3 ± 6.1 pA/pF, n = 12, n = 12) by comparison to drug-free controls (-23.3 ± 1.6 pA/pF, n = 9, ttest, p<0.05). The increase in Na v 1.8 immunostaining along the cell periphery ( Figure 1) and the parallel increase in Na current density are consistent with our working hypothesis that pre-incubating cells with lidocaine promotes the re-distribution of functional Na v 1.8 channels from intracellular compartments to the plasma membrane.
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In order to test if the expressed Na v 1.8 current were resistant to block by TTX, we tested the effect of 10µM TTX on our Na currents, a concentration that is known to significantly block the TTX sensitive channels. A concentration of TTX of 10µM resulted in only 16% reduction of Na current (Figure 4) , suggesting that the expressed channels are TTX resistant.
Activation and inactivation of the heterologously expressed Na v 1.8 channel The voltage-dependent activation of Na v 1.8 was assessed from the peak Na conductance and plotted versus test voltage ( Figure 5B ). The smooth curve is a fit to a Boltzmann function with midpoint and slope factor of -0.6 ± 1.9 mV and 13.6 ± 1.0 mV respectively (Table 1) . Also plotted is the steady-state inactivation determined by applying 500 ms pre-pulses to voltages between -140 and +10 mV. The availability determined from the peak current amplitudes of standard test pulses was normalized and plotted versus voltage ( Figure 5B ). The smooth curve is a fit to a double Boltzmann function with midpoints of -75.1 ± 1.4 mV and -34.4 ± 3.3 mV respectively with the majority of the reduction in availability (76%) being associated with the more hyperpolarized component (n=9, A H = 0.76 ± 0.03 mV, Table 1 ). Relatively small but statistically not significant differences in the steady-state activation and inactivation of lidocaine-treated and drug-free controls were observed ( Figure 5B ).
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The biphasic steady-state inactivation ( Figure 5B ) suggests that more than one gating process may contribute to the inactivation of Na v 1.8 over a hyperpolarized range of voltages. To further investigate the underlying mechanism(s) we varied the duration of the depolarizing conditioning pulses used to induce steady-state inactivation. Figure 6A plots the normalized test currents versus the voltage for conditioning durations of 50, 100, and 500 ms. The smooth curves are double Boltzmann fits with midpoints of -75.1 and -34.4 mV for the 500 ms pre-pulses (A H = 0.76), -75.0 and -31.5 mV for the 100 ms prepulses (A H = 0.67) and -75.2 and -33.6 mV for the 50 ms pre-pulses (A H = 0.53).
Shortening the duration of the prepulses had no effect on the midpoints of inactivation but significantly reduced the relative amplitude (A H ) of the more hyperpolarized component (t-test, p<0.05). These finding indicate that the longer prepulses (>50 ms)
promoted the entry of Na v 1.8 channels into a slow inactivated state that inactivated over a more hyperpolarized range of voltages.
To directly investigate the contribution of slow inactivation to the steady-state availability a triple pulse protocol was employed consisting of a 500 ms conditioning pulse to induce inactivation followed by a short hyperpolarization (-140 mV/10 ms) to permit the recovery from fast inactivation. A standard test pulse was then applied to assay availability. The relative amplitude of the test pulses decreases with depolarization, consistent with a progressive increase in slow inactivation ( Figure 6B ). The smooth curve is a fit to a Boltzmann function with midpoint (V 1/2 ) of -71.6 ± 1.8 mV and relative amplitude of 0.39 ± 0.01 (n=12). The midpoint of steady-state slow inactivation and amplitude are similar to the hyperpolarized component of availability (V 1/2 =-71.6, A H =0.51) obtained using conventional steady-state inactivation protocols (Table 1 ). The kinetics of closed-state inactivation at hyperpolarized voltages was also investigated ( Figure 7A ). The closed-state inactivation time course was biexponential with fast and slow time constants. For example the time constants at -70 mV are 15.2 ± 1.7 ms and 211.1 ± 22.2 ms respectively (n=18). The amplitude of the fast time constant represents 31%. These data further support the conclusion that Na v 1.8 channels readily enter into slow inactivated states at hyperpolarized voltages where the channels do not open.
The time course of recovery from inactivation was investigated using a double-pulse protocol consisting of a depolarizing prepulse (+15 mV/20 ms) to inactivate the channels, Figure 7B ). The normalized test currents progressively increase with the duration of the recovery interval consistent with the rapid recovery from inactivation.
At -120 mV, the recovery time course was biexponential with fast and slow time constants of 1.8 ± 0.3 ms and 12.7 ± 3.4 ms respectively (n=11, A f =0.53).
The biexponential kinetics of closed-state inactivation ( Figure 7A ), the recovery ( Figure 7B ) and the biphasic Boltzmann relationship ( Figure 6A ) indicate that both fast and slow inactivation are important determinants of the steady-state availability of the Na v 1.8 channel. ( Figure 8E ). The data were well fitted with a straight line yielding a single-channel conductance of 11 ± 0.4 pS.
Na v 1.8 single channel currents
Properties of the TTX-resistant Na current of DRG neurons
Preincubating with lidocaine increased the cell surface expression (Figure 1 ) and Na current density (Figure 3 ) of tsA201 cells transiently transfected with the Na v 1.8 channel.
Although these data are consistent with an increase in the expression of functional Na v 1.8 channels in the plasma membrane, it is important to ascertain that the resulting Na currents have properties that are similar to the native TTX-R current of DRG neurons.
We therefore directly compared the properties of the heterologously expressed Na v 1.8
and native DRG Na current. Figure 9 shows whole-cell Na current recordings from a dissociated DRG neuron before and after external application of TTX ( Figure 9 ). TTX reduced the peak current amplitude and slowed the kinetics of current decay, consistent with the selective inhibition of the rapidly gating TTX-S Na current expressed in these neurons. Figure 9D shows the current-voltage relationships of these Na currents.
Consistent with what has been previously reported, the TTX-R current of DRG neurons activates at more depolarized voltages and displays slow gating kinetics by comparison to the TTX-S current (Elliott and Elliott 1993). Figure 10A shows the normalized conductance and steady-state availability of the TTX-R Na current of DRG neurons. The voltage-dependent activation of the TTX-R current was fitted by a Boltzmann function with a midpoint of -13.8 ± 1.7 mV (n = 11).
Also plotted is the steady-state inactivation obtained using 500 ms prepulses to voltages between -120 and 0 mV. The data were best fitted by the sum of two Boltzmann functions with midpoints of -77 ± 4 mV and -32 ± 2 mV (n=8) respectively and are in good agreement with those determined for the heterologously expressed Na v 1.8 channel (Table 1 ). The time course of recovery from inactivation was bi-exponential with fast ( f ) and slow ( s ) time constants of 0.9 ± 0.4 ms and 74.5 ± 12.0 ms (A f =0.74, n = 3) respectively ( Figure 10B ). By comparison to heterologously expressed Na v 1.8, fewer of the endogenous TTX-R channels recovered with the slower time constant (53% for TTX-R versus 75% for Na v 1.8). This is consistent with measurements of steady-state inactivation where the relative fraction of native TTX-R channels inactivating at the more observed for the heterogously expressed Na v 1.8 channels (A H =0.76 ± 0.03, n = 9). In addition, the endogenous TTX-R channels that entered into the slow inactivated state recovered slowly ( s = 74.6 ms) by comparison to the heterologously expressed channels ( s = 12.7 ms). These data suggest significant differences in the slow inactivation of the endogenous and heterologously expressed Na v 1.8 channels. Figure 10C shows the time constants of current decay at depolarized voltages where Na v 1.8 channel open before inactivating. The current decay is biexponential with the rapid accounting for the majority (75-99%) of the current decay at voltages between 0 and +35 mV. The time constants and relative amplitudes of the fast and slow components are similar to what was observed for the heterologously expressed Na v 1.8 channel ( Figure 5A ).
Discussion
The Na v 1.8 channel is preferentially expressed in unmyelinated (C-type) and thinly Establishing an approach for heterologously expressing Na v 1.8 in cells that are devoid of endogenous Na current would enable a more detailed characterization of the channel.
Unfortunately, the heterologously expression of the cloned Na v 1.8 channel in mammalian cell lines has proved to be problematic (Fitzgerald et al. 1999; Okuse et al. 2002; John et al. 2004; Choi et al. 2004; Zhou et al. 2003; Vijayaragavan et al. 2001; . Na v 1.8 transfection of cultured cell lines often results in peak Na currents (<1 nA) that are considerably smaller than the endogenous TTX-R current of isolated DRG sensory neurons (>10 nA). Although the reason for this low level of expression is not known, it may be caused by a trafficking defect that prevents the incorporation of Na v 1.8
Page 16 of 42 channels into the plasma membrane (Okuse et al. 2002) . Co-expression of accessory proteins have been shown to increase heterologously expressed Na v 1.8 currents (Vijayaragavan et al. 2001; John et al. 2004) , however the mechanisms that govern the cell surface expression of these channels remains poorly understood.
In this study we found that pre-incubating Na v 1.8 transfected tsA201 cells with lidocaine produced a 6-fold increase in the amplitude of the TTX-R Na current. To further investigate the underlying mechanism we directly compared the biophysical properties of the TTX-R currents of lidocaine-treated tsA201 cells with the native TTX-R Na current of dissociated rat DRG neurons. Both the Na v 1.8 and native TTX-R Na currents activated at voltages around -50 mV. The time constants of current decay were similar for both Na currents indicating that the underlying channels slowly inactivate at depolarized voltages where the channels were predominately open ( Figure 5C and Figure   10A and B). Single channel recordings of the heterogously expressed channel displayed repetitive opening during sustained depolarization that appears to account for the slow time course of inactivation and the small persistent currents observed in macroscopic recordings ( Figure 3B ). The single-conductance of heterologously expressed Na v 1.8 was 11 ± 1.0 pS ( Figure 8D ) and is in good agreement with that previously reported for the endogenous TTX-resistant Na current of DRG neurons (Rush et al. 1998 ).
The activation of the heterologously expressed Na v 1.8 and native TTX-R Na currents had midpoints (V 1/2 ) of -0.6 and -13.8 mV respectively (Table 1) . The relatively hyperpolarized midpoint of activation observed for the endogenous TTX-R current is similar to what has been previously reported (Liu et al. 2006; Akiba et al. 2003) . We speculate that the difference in the activation of the heterologously expressed and endogenous Na currents may be related to the expression of additional components of TTX-R current (Na v 1.5 and Na v 1.9) in DRG neurons but not tsA201 cells (Fang et al. 2002; Renganathan et al. 2002) . Alternatively, DRG neurons may express additional subunits or accessory proteins that regulate the gating of the Na v 1.8 channel.
The steady-state inactivation of heterologously expressed Na v 1.8 obtained using 500 ms pre-pulses was fitted by a double Boltzmann function with midpoints of -75.1 ± 1.4 mV and -34.4 ± 3.3 mV indicating that two distinct components of inactivation contribute to the availability of the heterologously expressed channels (Table 1) . We
Page 17 of 42
found that shortening the depolarizing pre-pulses from 500 ms to 50 ms had no effect on the midpoints (V 1/2 ) of inactivation but significantly reduced the relative amplitude of the more hyperpolarized component ( Figure 6A ). The data suggested that the longer prepulses recruited channels into slow inactivated states that inactivated over a more hyperpolarized range of voltages. To test this mechanism we directly measured the steady-state slow inactivation of Na v 1.8 channels ( Figure 6B ), which had a midpoint (V 1/2 = -71.6 ± 1.8 mV) that was nearly identical to the more hyperpolarized component of inactivation (V 1/2 = -75.1 ± 1.4 mV) obtained using the conventional protocols for measuring steady-state availability ( Figure 5D ). The data indicate that Na v 1.8 channels rapidly enter into slow inactivated states at hyperpolarized voltages and that both fast and slow inactivation are important determinants of the steady-state availability of Na v 1.8 channels. Consistent with this hypothesis is the time course of the development of inactivation at hyperpolarized voltages where Na v 1.8 channels do not open before inactivating, which was found to be biexponetial ( Figure 5A ). The time constant of the slow component was in a range of 161 to 211 ms and appears to be associated with the entry of Na v 1.8 channels into a slow inactivated state. The hallmark of Na v 1.8 is its insensitivity to TTX, still our data show that the expressed Na channels were resistant to block by TTX (Figure 4 ).
The steady-state availability of the endogenous TTX-R current of DRG neurons was fitted by a double Boltzmann with midpoints of -77.1 and -31.6 mV, similar to what was observed for the heterologously expressed channels (Figure 10 ). Although the midpoints of fast and slow inactivation of the Na v 1.8 and TTX-R currents were similar, the relative contributions of these components to the steady-state availability substantially differed.
When applying 500 ms depolarizing pre-pulses the majority (88%) of the native TTX-R current was associated with the more depolarized component ( Figure 10A ) versus only 24% for heterologously expressed Na v 1.8 ( Figure 6A ). By comparison to the heterologously expressed channels, the endogenous TTX-R channel of DRG neurons appeared to be more resistant to entry into the slow inactivated state. We speculate that this may result from differential regulation of the expressed and endogenous channels by accessory subunits or intracellular signalling pathways that are unique to DRG neurons.
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Overall, the slow open-state inactivation ( Figure 5A ), the relatively depolarized midpoints of activation and inactivation ( Figure 5B ), and the rapid recovery from inactivation ( Figure 7B ) are similar for the heterologous expressed Na v 1.8 and native TTX-R Na currents. These data indicate that pre-incubating tsA201 cells with lidocaine selectively increased the cell surface expression of Na v 1.8 channels but did not significantly alter their biophysical properties. The activation and steady-state inactivation of the Na v 1.8 channel considerably overlap between -60 and 0 mV suggesting that depolarizing window currents may contribute to the resting membrane potential of DRG neurons expressing this channel.
The increase in Na v 1.8 current density produced by lidocaine suggested that preincubating with the drug promoted the translocation of Na v 1.8 channels to the plasma membrane. To further investigate the underlying mechanism, we examined the subcellular distribution of the heterologously expressed Na v 1.8 channels using confocal fluorescent imaging. In control experiments, the Na v 1.8 immunostaining largely overlapped with that of calnexin, a specific marker of endoplasmic reticulum (Figure 1 ).
When expressed in tsA201 cells the majority of the Na v 1.8 channel protein appears to be trapped within the endoplasmic reticulum, which would account for the relatively low Na current density of the transfected cells ( Figure 3A ). Pre-incubating the transfected cells with lidocaine resulted in a substantial shift of Na v 1.8 immunofluorescence from the cytoplasm to the cell membrane that correlated with an increase in the Na current density ( Figure 3D ). Western blot analysis indicated that the increase in cell surface immunostaining and Na current density induced by lidocaine was not associated with a parallel increase in the expression of the Na v 1.8 channel protein (Figure 2 ). Rather these findings indicate that the increase in functional Na channels results from the redistribution of pre-existing Na v 1.8 channels from the cytoplasmic compartment to the plasma membrane. These data suggest that the overall poor expression of the Na v 1.8 in tsA201 cells, and possibly other mammalian cell lines (Fitzgerald et al. 1999; Okuse et al. 2002) , results from a trafficking defect that causes channel protein to become trapped in the endoplasmic reticulum. The local anesthetic lidocaine is a potent inhibitor of the Na v 1.8 channel that is known to act by stabilizing Na channels in non-conducting inactivated states (Chevrier et al. 2004 ). However we cannot rule out the possibility that Although the state of Na channel in the ER is not known, we speculate that the lidocainemodified Na v 1.8 channels are stabilized in a conformational that facilitates the trafficking of the channels to the plasma membrane. Currents were elicited by depolarizing steps between -100 and + 90 mV in 10 mV increments from a holding potential of -140 mV. C. The peak Na current at each voltage was normalized to the whole-cell capacitance and the current density (pA/pf) plotted versus the test voltage (control, n = 9; lidocaine treated, n = 12). D. At +20 mV, preincubating with lidocaine produced a significant 6-fold increase in the Na current density (-123.3 ± 6.1 pA/pf, n = 12) by comparison to the drug-free controls (-23.3 ± 1.6
pA/pf, n = 9, t-test: p<0.01). The holding potential is -140 mV. Solid black line is the control current. The dotted line shows current in the presence of 10 µM TTX for 10 min, the peak current amplitude were inhibited by 16.02 ± 2.6% (n = 7). Medium dashed line shows the zero current. Na v 1.8/ 1 transfected controls (n=9) and -0.6 ± 1.9 mV/13.6 ± 1.0 mV for cells preincubated with lidocaine (n=12). Steady-state inactivation was determined using 500 ms prepulses to voltages between -140 and +5 mV. Steady-state availability was assayed using a standard test pulse ( and -32.9 ± 1.8 mV/9.4 ± 1.0 mV for depolarized component (n=14). Also plotted is the steady-state availability of the drug-free controls, which had a midpoints and slope factors of -73.4 ± 2.8 mV/10.8 ± 1.3 mV for the more hyperpolarized component and -31.3 ± 3.4 mV/11.5 ± 1.9 mV for the depolarized component (n=7).
Figure 6. Slow inactivation is an important determinant of steady-state availability
Na v 1.8 and 1 subunits were expressed in tsA201 cells and exposed to 1 mM lidocaine for 24 hours prior to recording. The steady-state availability was determined by applying prepulses of variable duration (50, 100, or 500 ms) to voltages between -140 and +5 mV.
A standard test pulse (20 mv/20 ms) was then used to assay availability. The test currents were normalized and plotted versus the prepulse voltage. A. The steady-state availability was determined using the 50, 100 and 500 ms prepulse durations. The smooth curves are fits to a double Boltzmann function with the parameters listed in Table 1 . B. Steady-state slow inactivation was determined by applying 500 ms to voltages between -140 and +5 mV. A short hyperpolarizing pulse (10 ms/-140 mV) was applied to permit recovery from fast inactivation and standard test pulse used to assay availability (+15 mV/20 ms).
The test currents were normalized and plotted versus voltage. The smooth curve is a fit to a Boltzmann function [I/I max = ((1-A)/(1+exp(( V-V 1/2 )/k v )))+A] with midpoint (V 1/2 ), slope factor (k v ) and steady-state availability (A) of -71.6 ± 1.8 mV, 11.8 ± 1.0 mV and 0.61 ± 0.02 respectively (n=12). 
A.
A. The conductance (G=I/(V-Vr)) was determined from the peak Na current (I) at each test voltage (V) and the reversal potential (Vr) determined from the current voltage relationships ( Figure 9D ). The conductance was normalized to that determined at +60 mV and plotted versus voltage. The smooth curve is a fit to a Boltzmann function with midpoint (V 1/2 ) and slope factor (k v ) of -13.8 ± 1.7 mV and 6.0 ± 0.6 mV respectively (n = 11). Steady-state inactivation was determined using 500 ms pre-pulses to the indicated Table 1 . B. Time course of recovery from inactivation.
Depolarizing prepulses (20 mV/75 ms) were applied before returning to a holding potential of -120 mV for a variable interval (0.05-1000 ms). The fractional recovery was determined using a standard test pulse (20 mV/10 ms). The test currents were normalized to the current measured after >1 second at -120 mV and plotted versus recovery interval.
The smooth curve is a fit to the sum of two exponentials with fast and slow time constants ( ) of 0.9 ± 0.38 ms and 74.5 ± 12.1 ms (A f =0.74 ± 0.05, n = 3). C. Time course of rapid inactivation. The decay phase of the TTX-R current measured at voltages more depolarized than -25 mV was fitted with the sum of two exponential components and the resulting fast ( fast ) and slow ( slow ) time constants plotted versus voltage (n = 8).
Page 25 of 42 Table 1 . Biophysical properties of Na v 1.8 currents in tsA201 cells after 1 mM lidocaine treatment and TTX-R currents in DRG neurons.
V 1/2 = the voltage at which the channels are half -maximal activated or inactivated V REC = recovery potential; K v = slope factor; = time constant a = the fraction of the total current represented by the first component (V 11.8 ± 1.0
